US2011125093A1PendingUtilityA1

Latex medical articles for release of antimicrobial agents

Assignee: BOSTON SCIENT SCIMED INCPriority: Jul 31, 2003Filed: Feb 4, 2011Published: May 26, 2011
Est. expiryJul 31, 2023(expired)· nominal 20-yr term from priority
Inventors:Sharon Tan
A61L 2300/404A61P 31/00A61L 29/16A61L 2300/10A61L 31/16A61L 29/042A61L 31/049A61L 2300/622A61L 2300/104
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

According to an aspect of the present invention, a medical article is provided which comprises a latex antimicrobial region. The latex antimicrobial region can constitute the entirety of the medical article, or it can constitute only a portion of the medical article. The latex antimicrobial region comprises release-modulating microparticles, which are dispersed within a latex polymer. The release-modulating microparticles further comprise an antimicrobial agent, and the microparticles are adapted to release the antimicrobial agent. Examples of medical articles that can be produced in accordance with the present invention are gloves, finger cots, supply and drainage tubes, catheters, condoms, and contraceptive diaphragms. Also described are methods for forming such articles.

Claims

exact text as granted — not AI-modified
1 . A medical article that comprises an antimicrobial region, said antimicrobial region comprising release-modulating microparticles dispersed within a latex polymer, said release-modulating microparticles comprising an antimicrobial agent and being adapted to release the antimicrobial agent. 
     
     
         2 . The medical article of  claim 1 , wherein said medical article is selected from gloves, finger cots, supply and drainage tubes, catheters, condoms and contraceptive diaphragms. 
     
     
         3 . The medical article of  claim 1 , wherein said medical article is a balloon catheter. 
     
     
         4 . The medical article of  claim 3 , wherein said antimicrobial region is a balloon sleeve. 
     
     
         5 . The medical article of  claim 1 , wherein said antimicrobial region is heat cured. 
     
     
         6 . The medical article of  claim 5 , wherein said antimicrobial region is vulcanized. 
     
     
         7 . The medical article of  claim 1 , wherein said microparticles comprise an encapsulating region that surrounds a region comprising said antimicrobial agent. 
     
     
         8 . The medical article of  claim 1 , wherein said microparticles comprise a core and an encapsulating layer surrounding said core, wherein said core comprises said antimicrobial agent, and wherein said encapsulating layer comprises a polymer. 
     
     
         9 . The medical article of  claim 1 , wherein said microparticles comprise a polymer, and wherein said antimicrobial compound is dispersed within said polymer. 
     
     
         10 . The medical article of  claim 1 , wherein said microparticles comprise an inorganic material, and wherein said antimicrobial compound is dispersed within said inorganic material. 
     
     
         11 . The medical article of  claim 10 , wherein said antimicrobial compound is dispersed within pores of said inorganic material. 
     
     
         12 . The medical article of  claim 1 , wherein said microparticles comprise a silver-containing ion exchange material. 
     
     
         13 . The medical article of  claim 1 , wherein said microparticles are silver-containing zeolite particles. 
     
     
         14 . The medical article of  claim 1 , wherein said antimicrobial agent comprises silver. 
     
     
         15 . The medical article of  claim 1 , wherein said latex polymer is formed from a natural latex. 
     
     
         16 . The medical article of  claim 1 , wherein said latex polymer is formed from a synthetic latex. 
     
     
         17 . The medical article of  claim 16 , wherein said synthetic latex is a pseudolatex. 
     
     
         18 . Wherein said release-modulating microparticles have an average largest dimension, on a weight average basis, ranging from 0.1 to 100 microns. 
     
     
         19 . A process for providing the antimicrobial region of  claim 1 , comprising: (a) providing a latex comprising said microparticles, (b) contacting said latex with a substrate, and (c) curing said latex thereby forming said antimicrobial region. 
     
     
         20 . The process of  claim 19 , wherein said substrate is a mold that is dipped into said latex.

Join the waitlist — get patent alerts

Track US2011125093A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.